BMS-986278
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for BMS-986278, covering 2025-01-22 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis [Phase 3]